Salem Investment Counselors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.39M Sell
69,705
-1,537
-2% -$134K 0.16% 90
2026
Q1
$6.07M Sell
71,242
-4,200
-6% -$374K 0.18% 85
2025
Q4
$5.96M Sell
75,442
-2,216
-3% -$174K 0.17% 84
2025
Q3
$6.21M Buy
77,658
+677
+0.9% +$57.8K 0.18% 84
2025
Q2
$7M Sell
76,981
-1,525
-2% -$139K 0.22% 73
2025
Q1
$7.36M Buy
78,506
+148
+0.2% +$13.3K 0.26% 65
2024
Q4
$7.12M Sell
78,358
-1,200
-2% -$115K 0.23% 62
2024
Q3
$8.26M Sell
79,558
-163
-0.2% -$16.6K 0.25% 59
2024
Q2
$7.74M Buy
79,721
+918
+1% +$84.7K 0.25% 61
2024
Q1
$7.1M Sell
78,803
-2,030
-3% -$172K 0.23% 64
2023
Q4
$6.44M Sell
80,833
-2,008
-2% -$151K 0.22% 67
2023
Q3
$5.89M Sell
82,841
-130
-0.2% -$9.72K 0.22% 69
2023
Q2
$6.39M Sell
82,971
-943
-1% -$73K 0.23% 66
2023
Q1
$6.31M Buy
83,914
+13,096
+18% +$974K 0.25% 71
2022
Q4
$5.58M Buy
70,818
+280
+0.4% +$21K 0.24% 71
2022
Q3
$4.96M Sell
70,538
-761
-1% -$59.7K 0.23% 72
2022
Q2
$5.71M Sell
71,299
-3,230
-4% -$253K 0.26% 66
2022
Q1
$5.65M Sell
74,529
-1,310
-2% -$104K 0.22% 70
2021
Q4
$6.47M Sell
75,839
-1,512
-2% -$118K 0.23% 69
2021
Q3
$5.85M Sell
77,351
-1,015
-1% -$80.6K 0.32% 69
2021
Q2
$6.38M Buy
78,366
+1,586
+2% +$130K 0.35% 63
2021
Q1
$6.05M Sell
76,780
-1,688
-2% -$132K 0.37% 61
2020
Q4
$6.71M Buy
78,468
+224
+0.3% +$18.5K 0.44% 58
2020
Q3
$6.04M Buy
78,244
+892
+1% +$68K 0.46% 53
2020
Q2
$5.67M Sell
77,352
-2,425
-3% -$172K 0.48% 51
2020
Q1
$5.29M Buy
79,777
+550
+0.7% +$38.8K 0.55% 46
2019
Q4
$5.45M Sell
79,227
-1,599
-2% -$109K 0.45% 56
2019
Q3
$5.94M Sell
80,826
-1,119
-1% -$81.2K 0.55% 48
2019
Q2
$5.87M Sell
81,945
-7,530
-8% -$535K 0.54% 48
2019
Q1
$5.99M Sell
89,475
-31
-0% -$2K 0.61% 39
2018
Q4
$5.33M Buy
89,506
+31
+0% +$1.94K 0.67% 38
2018
Q3
$5.99M Sell
89,475
-597
-0.7% -$39.8K 0.61% 39
2018
Q2
$6.37M Sell
90,072
-9,435
-9% -$617K 0.58% 37
2018
Q1
$7.04M Sell
99,507
-1,808
-2% -$130K 0.8% 33
2017
Q4
$7.64M Buy
101,315
+820
+0.8% +$59.9K 0.83% 32
2017
Q3
$7.36M Sell
100,495
-18,657
-16% -$1.34M 0.86% 33
2017
Q2
$8.83M Buy
119,152
+19,119
+19% +$1.42M 1.02% 28
2017
Q1
$7.32M Buy
100,033
+410
+0.4% +$28.7K 0.78% 36
2016
Q4
$6.52M Buy
99,623
+3,902
+4% +$268K 0.75% 37
2016
Q3
$71K Sell
95,721
-850
-0.9% -$62.8K 0.93% 33
2016
Q2
$7.07M Sell
96,571
-450
-0.5% -$32K 0.85% 35
2016
Q1
$6.86M Sell
97,021
-120
-0.1% -$7.98K 0.85% 37
2015
Q4
$6.47M Sell
97,141
-7,080
-7% -$471K 0.82% 38
2015
Q3
$6.55M Buy
104,221
+1,800
+2% +$118K 0.86% 36
2015
Q2
$6.7M Sell
102,421
-1,325
-1% -$89.9K 0.81% 33
2015
Q1
$7.19M Sell
103,746
-200
-0.2% -$13.8K 0.86% 33
2014
Q4
$7.19M Sell
103,946
-550
-0.5% -$37.1K 0.86% 36
2014
Q3
$6.82M Buy
104,496
+475
+0.5% +$31.3K 0.82% 38
2014
Q2
$7.09M Buy
104,021
+3,050
+3% +$204K 0.86% 35
2014
Q1
$6.55M Buy
100,971
+490
+0.5% +$30.9K 0.81% 41
2013
Q4
$6.55M Buy
100,481
+2,600
+3% +$166K 0.85% 37
2013
Q3
$5.8M Sell
97,881
-175
-0.2% -$10.4K 0.81% 38
2013
Q2
$5.62M Buy
+98,056
New +$5.82M 0.81% 39

Other funds holding CL

Salem Investment Counselors's CL Position: Q2 2026 in Review

Salem Investment Counselors reduced its Colgate-Palmolive (CL) stake by 2.2% in Q2 2026, selling an estimated $134K and leaving 69,705 shares worth $6.39M. The position accounts for 0.16% of the portfolio, ranked #90.

Salem Investment Counselors first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.83M in Q2 2017. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Salem Investment Counselors held 69,705 shares of Colgate-Palmolive worth $6.39M as of Q2 2026.
  • Salem Investment Counselors sold 1,537 Colgate-Palmolive shares in Q2 2026, an estimated $134K.
  • Colgate-Palmolive made up 0.16% of Salem Investment Counselors's portfolio in Q2 2026, its #90 holding.
  • Salem Investment Counselors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Salem Investment Counselors's Colgate-Palmolive position peaked at $8.83M in Q2 2017.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.